Gupta AK, Wang T, Rapaport JA (2023): Systematic review of exosome treatment in hair restoration: Preliminary evidence, safety, and future directions
Aditya K. Gupta, Tong Wang, Jeffrey A. Rapaport · Journal of Cosmetic Dermatology, 2023PMID: 37381168
Supports: Systematic review of 16 studies (15 preclinical, 1 clinical) demonstrating efficacy of exosomes derived from ADSCs and dermal papilla cells for hair restoration. Topical ADSC-exosomes showed significant increases in hair density and thickness in 39 androgenetic alopecia patients. No significant adverse reactions reported.
Limitations: Only 1 clinical study identified out of 16 total. Current clinical evidence remains limited. Further studies needed to define mechanism of action, optimise delivery and efficacy, and address long-term safety.
View on PubMed →Shah M, Dukharan V, Broughton L, et al. (2025): Exosomes for Aesthetic Dermatology: A Comprehensive Literature Review and Update
Milaan Shah, Victoria Dukharan, Luke Broughton, Carol Stegura, Nina Schur, Luna Samman, Todd Schlesinger · Journal of Cosmetic Dermatology, 2025PMID: 39764639
Supports: Comprehensive literature review confirming early evidence supports efficacy of exosomes for alopecia, hair rejuvenation, facial rejuvenation, hyperpigmentation, and scarring. Clinical cases demonstrated promising improvements across all indications.
Limitations: Lack of standardisation in exosome production and application protocols. Consensus on outcomes not yet established. Further investigation required to fully characterise the scope of clinical application.
View on PubMed →Darwish R, Zakhary M, Wingate K, et al. (2025): From Cells to Strands: A Systematic Review Comparing Exosome Therapy, Platelet-Rich Plasma, and Minoxidil for Androgenetic Alopecia Treatment
Rajah Darwish, Marina Zakhary, Kaleigh Wingate, Noura Ayoubi, Faisal Ghafoor, Bushra Ejaz · Cureus, 2025PMID: 40821339
Supports: Systematic review comparing exosome therapy, PRP, and minoxidil for androgenetic alopecia. Exosome therapy demonstrated the most promising results for hair regrowth and safety. PRP offered moderate benefits. Exosome therapy holds the greatest potential for long-term improvement.
Limitations: Further research needed to guide clinical decision-making and optimise treatment outcomes. Minoxidil remains the most accessible treatment despite more limited effectiveness.
View on PubMed →Vitale M, Ruri P, Marini S, et al. (2025): Clinical Outcomes of Exosome-Augmented Microneedling and Laser Therapies in Full-Face Skin Rejuvenation: A Split-Face Observational Study
Massimo Vitale, Pamela Ruri, Sousanna Marini, Elena Zappia, Kyu-Ho Yi · Journal of Craniofacial Surgery, 2025PMID: 40892048
Supports: Split-face study in 9 women (aged 30–50) demonstrated exosome-treated sides showed greater improvements in texture, hydration, elasticity, and pigmentation at 30, 90, and 180 days. Most notable gains occurred with microneedling + exosomes and CO2 laser + exosomes.
Limitations: Small sample size (9 participants). Picosecond laser showed less distinct exosome benefit, possibly due to pinpoint bleeding reducing absorption. Larger studies warranted to optimise delivery and confirm long-term regenerative effects.
View on PubMed →*PRP London Clinic provides these references for educational purposes. Our Clinical Board regularly reviews emerging peer-reviewed literature to ensure our protocols align with the latest advancements in regenerative medicine.